Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant PCV Chemotherapy and Radiation Therapy in Anaplastic Oligodendroglioma
NCT00002840Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 1996
- Primary completion
- Mar 2002
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of procarbazine, lomustine, vincristine in anaplastic oligodendroglioma (AO), sponsored by European Organisation for Research and Treatment of Cancer. Started Aug 1996; status: completed.
02
Drugs
procarbazinelomustinevincristine
03
Conditions
anaplastic oligodendroglioma (AO)
Beyond the preview
Go deeper on NCT00002840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002840.